SkinBioTherapeutics (LSE:SBTX) Inventories, Finished Goods: £0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:SBTX SkinBioTherapeutics PLC LSE:SBTX
37 GF Score
Price £0.12
GF Value £0.66
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is SkinBioTherapeutics Inventories, Finished Goods?

SkinBioTherapeutics LSE:SBTX -2.08% 37 Inventories, Finished Goods is £0.00 Mil as of Dec. 2025. GuruFocus rates LSE:SBTX with a GF Score™ of 37/100 and a GF Value™ of £0.66 (Possible Value Trap). The stock has 3 warning signs investors should review.

SkinBioTherapeutics Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for SkinBioTherapeutics's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SkinBioTherapeutics Inventories, Finished Goods Chart

SkinBioTherapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SkinBioTherapeutics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LSE:SBTX
37GF Score
SkinBioTherapeutics PLC LSE:SBTX
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SkinBioTherapeutics Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of £0.00 Mil mean?
SkinBioTherapeutics (LSE:SBTX) has a Inventories, Finished Goods of £0.00 Mil as of Dec. 2025. Finished goods are inventory items that are complete and ready to be sold. View historical data on SkinBioTherapeutics and its competitors.
Is SkinBioTherapeutics' Inventories, Finished Goods too high?
SkinBioTherapeutics' current Inventories, Finished Goods is £0.00 Mil. Overall, SkinBioTherapeutics has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SkinBioTherapeutics' Inventories, Finished Goods compare to VRTX and REGN?
SkinBioTherapeutics' Inventories, Finished Goods of £0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Biotechnology company?
A good Inventories, Finished Goods depends on the Biotechnology industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on SkinBioTherapeutics and its competitors. SkinBioTherapeutics's current Inventories, Finished Goods is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SkinBioTherapeutics stock overvalued right now?
Based on GuruFocus' analysis, SkinBioTherapeutics (LSE:SBTX) is currently considered Possible Value Trap. The stock's GF Value™ is £0.66, compared to a current price of £0.12 — trading 82.2% below its estimated fair value. The current Inventories, Finished Goods is £0.00 Mil. SkinBioTherapeutics' overall GF Score™ is 37/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For SkinBioTherapeutics (LSE:SBTX), the current Inventories, Finished Goods is £0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SkinBioTherapeutics (LSE:SBTX) Overvalued in 2026?

Based on GuruFocus' analysis, SkinBioTherapeutics stock appears to be undervalued. The current stock price of £0.12 is trading 82.2% below its estimated GF Value™ of £0.66. GuruFocus considers SkinBioTherapeutics to be Possible Value Trap.

Key valuation signals for LSE:SBTX:

  • Inventories, Finished Goods: £0.00 Mil
  • GF Value™: £0.66 vs. price of £0.12 (82.2% below fair value)
  • GF Score™: 37/100 with 3 warning signs

No single metric tells the full story. See the LSE:SBTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SkinBioTherapeutics Business Description

Address Bath Lane, The Core, Newcastle Helix, Newcastle upon Tyne, GBR, NE4 5TF
SkinBioTherapeutics PLC is a life science company focused on skin health. It is focused on the development of technology to protect, manage, and restore skin utilizing proteins found in the human microbiota. It is targeting three specific skin healthcare sectors; cosmetics, infection control, and eczema.
37GF Score

Get the complete analysis for LSE:SBTX

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.12
Price
£0.66
GF Value